Schedule 13D ownership disclosure

INDAPTUS THERAPEUTICS INC

Common Stock, $0.01 par value per share · CUSIP: 45339J105

Event date: 2025-12-22

Filing-level shares
273,103.00
Percent of class
12.7%
  • Jeffery A. MecklerReported CIK 0001506916

    Shares: 273,103.00 · Class: 12.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-029594
Form type
SCHEDULE 13D/A
Filer
Indaptus Therapeutics, Inc.
CIK
CIK 1857044
Filed
Dec 30, 2025
Reporting period
Dec 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub